单克隆抗体和多发性骨髓瘤：这一切是否仅仅是另一个挡箭牌？
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?
机构信息
Scientific Direction, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy
出版信息
Oncologist. 2018 May;23(5):511-515. doi: 10.1634/theoncologist.2018-0097. Epub 2018 Apr 26.
Abstract
This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.
摘要
本文就近期欧洲药品管理局（EMA）对达雷妥尤单抗（daratumumab）治疗多发性骨髓瘤（MM）成年患者的审批进行了评估，并提供了相关见解。
相似文献
1
Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?
Oncologist. 2018 May;23(5):511-515. doi: 10.1634/theoncologist.2018-0097. Epub 2018 Apr 26.
2
Incorporating monoclonal antibodies into the management of multiple myeloma.
Clin Adv Hematol Oncol. 2017 Dec;15(12):919-922.
3
Evolution of monoclonal antibodies in multiple myeloma.
Lancet Oncol. 2018 Dec;19(12):1554-1555. doi: 10.1016/S1470-2045(18)30647-8. Epub 2018 Nov 12.
4
Infectious and immunological sequelae of daratumumab in multiple myeloma.
Br J Haematol. 2019 Apr;185(1):187-189. doi: 10.1111/bjh.15433. Epub 2018 Jul 5.
5
Current use of monoclonal antibodies in the treatment of multiple myeloma.
Br J Haematol. 2018 May;181(4):447-459. doi: 10.1111/bjh.15121. Epub 2018 Apr 25.
6
In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab.
Leukemia. 2020 Jan;34(1):317-321. doi: 10.1038/s41375-019-0536-3. Epub 2019 Aug 13.
7
Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.
Curr Med Chem. 2019;26(32):5968-5981. doi: 10.2174/0929867325666180514114806.
8
Advancement in monoclonal antibody therapy for multiple myeloma.
Lancet Haematol. 2020 May;7(5):e354-e355. doi: 10.1016/S2352-3026(20)30098-3. Epub 2020 Mar 23.
9
Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action.
Best Pract Res Clin Haematol. 2020 Mar;33(1):101143. doi: 10.1016/j.beha.2020.101143. Epub 2020 Jan 11.
10
Monoclonal antibodies as an addition to current myeloma therapy strategies.
Expert Rev Anticancer Ther. 2021 Jan;21(1):33-43. doi: 10.1080/14737140.2021.1837627. Epub 2020 Oct 26.
本文引用的文献
1
Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS).
Leukemia. 2020 Jul;34(7):1840-1852. doi: 10.1038/s41375-020-0718-z. Epub 2020 Feb 5.
2
Ninety-minute daratumumab infusion is safe in multiple myeloma.
Leukemia. 2018 Nov;32(11):2495-2518. doi: 10.1038/s41375-018-0120-2. Epub 2018 Mar 31.
3
EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma.
Oncologist. 2018 May;23(5):594-602. doi: 10.1634/theoncologist.2017-0328. Epub 2018 Jan 25.
4
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.
Leukemia. 2018 Feb;32(2):252-262. doi: 10.1038/leu.2017.329. Epub 2017 Nov 16.
5
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12.
6
Management of multiple myeloma in the relapsed/refractory patient.
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):508-517. doi: 10.1182/asheducation-2017.1.508.
7
From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.
Haematologica. 2018 Feb;103(2):197-211. doi: 10.3324/haematol.2017.174573. Epub 2017 Dec 7.
8
CD38 antibodies in multiple myeloma: back to the future.
Blood. 2018 Jan 4;131(1):13-29. doi: 10.1182/blood-2017-06-740944. Epub 2017 Nov 8.
9
Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14).
Eur J Haematol. 2018 Feb;100(2):215-217. doi: 10.1111/ejh.12986. Epub 2017 Nov 16.
10
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
Blood. 2017 Nov 30;130(22):2401-2409. doi: 10.1182/blood-2017-06-788786. Epub 2017 Oct 10.
Zotero 插件